Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB00108_nanopub.RAmljVjvR_BCFzt8MtOOzSPgUsl4QopSG9g_ywN54QVLc#assertion>. }
Showing items 1 to 21 of
21
with 100 items per page.
- drugbank:DB00108 type drugbank_vocabulary:Drug assertion.
- drugbank:DB00108 label "Natalizumab [drugbank:DB00108]" assertion.
- drugbank:DB00108 seeAlso tysabri.htm assertion.
- drugbank:DB00108 seeAlso natalizumab.html assertion.
- drugbank:DB00108 seeAlso DB00108 assertion.
- drugbank:DB00108 description "Humanized IgG4k monoclonal antibody produced in murine myeloma cells. Natalizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to a4-integrin. Natalizumab was voluntarily withdrawn from U.S. market because of risk of Progressive multifocal leukoencephalopathy (PML). It was returned to market July, 2006." assertion.
- drugbank:DB00108 identifier "drugbank:DB00108" assertion.
- drugbank:DB00108 title "Natalizumab" assertion.
- drugbank:DB00108 drugbank_vocabulary:x-cas cas:189261-10-7 assertion.
- drugbank:DB00108 drugbank_vocabulary:drugbank-id "BIOD00083" assertion.
- drugbank:DB00108 drugbank_vocabulary:drugbank-id "BTD00083" assertion.
- drugbank:DB00108 drugbank_vocabulary:drugbank-id "DB00108" assertion.
- drugbank:DB00108 bio2rdf_vocabulary:x-identifiers.org DB00108 assertion.
- drugbank:DB00108 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB00108" assertion.
- drugbank:DB00108 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB00108 bio2rdf_vocabulary:identifier "DB00108" assertion.
- drugbank:DB00108 drugbank_vocabulary:x-wikipedia wikipedia:Natalizumab assertion.
- drugbank:DB00108 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164747191 assertion.
- drugbank:DB00108 drugbank_vocabulary:x-dpd dpd:2286386 assertion.
- drugbank:DB00108 drugbank_vocabulary:x-ahfs ahfs:92:00.00 assertion.
- drugbank:DB00108 drugbank_vocabulary:x-ndc ndc:59075-730-15 assertion.